Pharmafile Logo

Kogenate

Bayer symbol

Bayer confirms bid for Monsanto; will pharma suffer?

Analysts fear agrochemical $62bn deal will hinder its medicines business

Bayer symbol

Excess deaths cause Bayer to halt riociguat trial

No indication that Adempas may be unsafe in its approved uses

Allergan logo

Allergan on course to file uterine fibroid drug next year

New drug could be safer and more effective than existing treatment

- PMLiVE

Plaudits for Bayer’s website

Ranked number two in Bowen Cragg's annual Index of Online Excellence

Bayer symbol

Bayer eyes liver cancer indication for Stivarga

New trial data shows improvement in overall survival in HCC patients

Biogen Idec building

Biogen plans spin-out of haemophilia business

Aims to create two 'agile' specialist firms

Take a walk on the wild side!

The Say Comms team are raising money for The Haemophilia Society with a walk-a-thon sponsor them here http://bit.ly/1MtvDO8

Say Communications

- PMLiVE

Japanese approvals for GSK, AZ and Bayer

MHLW gives Nucala, Tagrisso and Xofigo the green light

- PMLiVE

Bayer appoints Dr Michael Preuss as new comms head

He takes over from Dr Herbert Heitmann

- PMLiVE

IQWiG unimpressed with Cosentyx in two new indications

Concludes Novartis drug has no added benefit in ankylosing spondylitis or psoriatic arthritis

Bayer symbol

Bayer picks strategy head for top post

Werner Baumann will take over from Dr Marijn Dekkers

Bayer symbol

Bayer gets first approval for Kogenate upgrade Kovaltry

First worldwide licence for the haemophilia treatment

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links